Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

BAT

Botulism Antitoxin Heptavalent

Standard Dose
Refer to label-specific dosage instructions.
Max Dose
See product label
Primary Use
Marketed liquid containing EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2.
Summary

Product profile Marketed liquid containing EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2.

Dose form and route LIQUID · INTRAVENOUS

Structured Monograph

Clinical summary

Product profile Marketed liquid containing EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2, EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2. Dose form and route LIQUID · INTRAVENOUS

Monitoring

  • • Review the product-specific label before prescribing.

Interaction Notes

  • • Interaction data should be confirmed against the corresponding label.